# Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments.

> **NCT05483387** · PHASE4 · UNKNOWN · sponsor: **KLS Martin** · enrollment: 60 (estimated)

## Conditions studied

- Intraarticular Fracture
- Extraarticular Fracture
- Pseudarthrosis
- Arthrosis

## Interventions

- **DEVICE:** Treatment with HBS 2 Resorb Mg

## Key facts

- **NCT ID:** NCT05483387
- **Lead sponsor:** KLS Martin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05483387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05483387, "Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05483387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*